Sign in

CIK 0001557746

  • Non-accelerated filer
  • Smaller reporting company

Aclaris Therapeutics, Inc.

Sign in to watch
Ticker
ACRS
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
Operating
EIN
460571712
Phone
+1 484-324-7933
Business address
701 LEE ROAD, SUITE 103, WAYNE, PA, 19087
Open-market buys, last 90 days
$0
in 0 filings
Open-market sales, last 90 days
$0
in 0 filings

Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Date Insider Transaction Shares Price Value Owned after
2019-02-01 Fair Brett Chief Commercial Officer Option exercise +3,875 11,890
2019-02-01 Fair Brett Chief Commercial Officer Shares withheld for taxes −1,308 $6.96 $9K 10,582
2019-02-01 Fair Brett Chief Commercial Officer Option exercise · Restricted Stock Units −3,875 11,625
2018-12-18 Fair Brett Chief Commercial Officer Option exercise +1,750 8,513
2018-12-18 Fair Brett Chief Commercial Officer Shares withheld for taxes −498 $6.30 $3K 8,015
2018-12-18 Fair Brett Chief Commercial Officer Option exercise · Restricted Stock Units −1,750 1,750
2018-12-15 Fair Brett Chief Commercial Officer Option exercise +1,013 7,051
2018-12-15 Fair Brett Chief Commercial Officer Shares withheld for taxes −288 $7.31 $2K 6,763
2018-12-15 Fair Brett Chief Commercial Officer Option exercise · Restricted Stock Units −1,013 2,025
2018-05-07 Fair Brett Chief Commercial Officer Option exercise +4,050 7,191
2018-05-07 Fair Brett Chief Commercial Officer Shares withheld for taxes −1,153 $18.10 $21K 6,038
2018-05-07 Fair Brett Chief Commercial Officer Option exercise · Restricted Stock Units −4,050 3,038

Page 1 of 1 · 12 trades